<DOC>
	<DOCNO>NCT00515489</DOCNO>
	<brief_summary>The purpose study evaluate safety risperidone treatment acute psychotic patient require admission emergency department . The effectiveness risperidone control acute psychotic symptomatology incidence , severity risk psychomotor agitation acute psychotic patient also study .</brief_summary>
	<brief_title>Study Safety Effectiveness Risperidone Treatment Acute Psychotic Patients</brief_title>
	<detailed_description>Antipsychotic drug key treatment acute psychotic symptom experience schizophrenic , schizoaffective disorder schizophreniform disorder patient . In last year , atypical antipsychotic few side effect conventional neuroleptic , introduce clinical practice . There agreement type drug use emergency situation ( acute psychotic patient ) . The aim observational , prospective study evaluate impact treatment regimen atypical antipsychotic drug , risperidone , first line treatment acute psychotic patient request admission hospital . Effectiveness risperidone treatment measure Positive Negative Syndrome Scale ( PANSS ) agitation sub scale , Brief Psychotic Rating Scale day in-patient period . Aggressive behavior rat use Staff Observation Aggression Scale ( SOAS ) Visual Analogic Scale agitation anxiety . Safety evaluate collect elicited adverse event . Observational study - Risperidone , 3-6 mg per day , orally , study period ( in-patient period patient ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Acute Psychotic symptom Schizophrenia Schizoaffective disorder Schizophreniform disorder patient require admission hospital physician consider use risperidone treatment clinical practice Pregnant lactating patient Patients psychiatry pathology Schizophrenia schizoaffective disorder Patients neurology pathology except Parkinsonism induce neuroleptic Patients severe concomitant pathology Patients treat risperidone last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Schizophreniform Disorders</keyword>
</DOC>